APA (7th ed.) Citation

M, Y., W, Z., L, L., D, O., J, A., U, K., . . . S, M. (2024). Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress. Neuro-oncology advances, 6(1), vdae109. https://doi.org/10.1093/noajnl/vdae109

Chicago Style (17th ed.) Citation

M, Yankelevich, Zaky W, Lafay-Cousin L, Osorio D, Adamski J, Kordes U, Finlay JL, Prados M, and Mueller S. "Marrow-ablative Consolidation Chemotherapy and Molecular Targeted Therapy Delivered in a Risk-adapted Manner for Newly Diagnosed Children with Choroid Plexus Carcinoma: A Work in Progress." Neuro-oncology Advances 6, no. 1 (2024): vdae109. https://doi.org/10.1093/noajnl/vdae109.

MLA (9th ed.) Citation

M, Yankelevich, et al. "Marrow-ablative Consolidation Chemotherapy and Molecular Targeted Therapy Delivered in a Risk-adapted Manner for Newly Diagnosed Children with Choroid Plexus Carcinoma: A Work in Progress." Neuro-oncology Advances, vol. 6, no. 1, 2024, p. vdae109, https://doi.org/10.1093/noajnl/vdae109.